PBL 1 : T1DM Flashcards

1
Q

What is the Islet of Langerhans and what does it secrete?

A

Cluster of endocrine cells in the pancreas which secrete endocrine hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what do alpha cells secrete? where are they found? and how much secretion do they contribute ?

A

Glucagon
Found around outer edge
around 20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What cells secrete insulin? Where are they found in the islet of Langerhans? how much secretion do they contribute?

A

Beta cells
Found in the middle
about 70%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what do delta cells secrete? how much secretion do they contribute ?

what do PP cells secrete and how much secretion do they contribute

A

Somatostatin
About 10%

secretes pancreatic polypeptide (2%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is insulin? Describe what it is made up of

A

Insulin is a polypeptide hormone

It consists of 2 short chains- alpha and beta linked by disulphide bonds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the steps int he synthesis of insulin

A

Insulin is synthesised as a pro-hormone:
 Insulin mRNA is translated as a single chain precursor called Preproinsulin
 Signal sequence is cleaved off to generate Proinsulin
 Endopeptidases cleave off the C-peptide to generate mature form of Insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is also packaged into granules along with insulin?

A

C peptide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the process of insulin release in response to post-prandial rise in glucose

A

1) Glucose enters the beta cells via GLUT2 transporter through facilitated diffusion
2) Glucose is then phosphorylated by glucokinase to generate glucose-6-phosphate, which is then metabolised via oxidative phosphorylation to produce ATP
3) Elevated ATP levels cause the ATP-dependant K+ channels to close, resulting in depolarisation (inside cell becomes more +ve since no K+ leaving)
4) Influx of Ca2+ ions into the cell via voltage-gates Ca channels
5) Ca2+ entry stimulates the vesicles containing insulin to fuse with plasma membrane and release insulin into the extracellular fluid by exocytosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

which chemicals/factors stimulate insulin secretion?

A
Amino acids e.g. arginine and leucine
Parasympathetic innervation
sulfonylurea
gastrointestinal tract peptides e.g. cholecystokinin
Incretins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

which chemicals/factors inhibit insulin secretion?

A

noradrenaline
sympathetic innervation
somatostatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what happens to remaining insulin which is not taken up by receptors on target cells?

A

remaining insulin is degraded by the enzyme insulinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

where are insulin receptors primarily found?

A

found on most tissues but primarily located in the liver, striated muscle and adipocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the binding of insulin to insulin receptors

A

The receptor is a tyrosine kinase which is made of 2 alpha and 2 beta units and phosphorylates itself.
 When insulin binds to the extracellular alpha subunits, the beta subunits become activated and undergo a conformational change.
 The Beta-subunit receptors auto phosphorylate themselves on tyrosine residues.
 Receptor tyrosine kinase activity begins an intercellular cascade of phosphorylation:
o The phosphorylated receptor forms a complex with and phosphorylates Insulin Receptor Substrate-1 (IRS)
(cascade of phosphorylation occurs)
 Eventually, this leads to translocation of GLUT4 transporters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

is insulin an anabolic or catabolic hormone?

A

anabolic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the actions of insulin - what it stimulates and inhibits

A

Stimulates:
• Glucose uptake (Muscle, adipocytes)
• Glycogen synthesis – (Muscle, liver)
• Fatty acid synthesis – glucose storage in form of lipids (Liver, adipocytes

Inhibits:
• Lipolysis – breakdown of lipids (adipose tissue)
• Gluconeogenesis – production of glucose from non-carbohydrate source

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

is glucagon an anabolic or catabolic hormone?

A

Catabolic hormone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

describe the synthesis of glucagon and where it occurs

A

Glucagon is synthesised as preproglucagon which is proteolytically cleaved in the alpha cell to produce proglucagon and then glucagon.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

where is the primary site of glucagon action in the body?

A

Liver

19
Q

which chemicals/factors stimulate glucagon secretion?

A

Drop in blood glucose
Adrenaline
Amino acids
Parasympathetic and sympathetic innervation

20
Q

which chemicals/factors inhibit glucagon secretion?

A

insulin
Somatostatin
Fatty acids
Ketones

21
Q

what type of receptors are glucagon receptors? where are they mostly found?

A

GPCRs, in liver

22
Q

describe the binding of glucagon to GPCR

A

 Glucagon binds to GPCR and causes a conformational change which activates G protein
 The G protein undergoes a conformational change which replaces GDP with a GTP
 This causes the activation of adenylyl cyclase which goes onto make cAMP
 cAMP acts as a second messenger to initiate a phosphorylation cascade

23
Q

Describe the actions of glucagon

A
  • Stimulates glycogenolysis (muscle, liver)
  • Stimulates gluconeogenesis (liver)
  • Enhances hepatic ketone production by promoting fatty acid conversion to ketone bodies (liver)
  • Promotes lipolysis (adipose tissue)Inhibits glucose uptake (muscle)
    • Inhibits glycolysis (muscle)
    • Inhibits fatty acid synthesis (adipose tissue)
24
Q

in response to which hormone do fatty acids and ketone levels increase?

A

Glucagon

25
Q

what percentage of diabetes does T1DM account for?

A

10%

26
Q

Describe the pathophysiology of T1DM

A

o In T1DM there is a genetic abnormality which causes a loss of self-tolerance among T cells which specifically target beta cell antigens.
o Loss of tolerance means these T cells can recruit other immune cells and coordinate a cell-mediated immune attack on beta cells.
o Losing beta cells means less insulin is made and glucose levels increase in blood
This results in autoimmune destruction of Beta-islet cells

27
Q

what are the normal fasting blood glucose levels ?

A

below or equal to 6 mmol/l

28
Q

What are Impaired fasting blood glucose levels ?

A

between 6.1 and 6.9 mmol/l

29
Q

What are diabetic fasting blood glucose levels ?

A

above or equal to 7 mmol/l

30
Q

An increased frequency of which HLA alleles is associated with T1DM?

A

DR3 and DR4

31
Q

problems with which genetic component increase susceptibility to T1DM?

A

MHC on chromsome 6

32
Q

List the risk factors of T1DM

A

Presence of other autoimmune diseases
Certain viruses
Environmental factors (COw’s milk, wheat proteins)
Insulin resistance (occurs transiently in puberty)
Increased age
Family history

33
Q

what are the 3 main autoantibodies found in T1DM and which is most prevalent?

A
o	GAD65 (Glutamic acid decarboxylase 65) – most prevalent 
o	ICA (Islet Cell Antibody)
o	I-A2 (Insulinoma-associated antigen 2)
34
Q

What are symptoms of T1DM?

A
thirst (polydipsia)
increased urge to urinate (Polyuria)
Tiredness
Unintentional weight loss 
Wounds that don't heal/prone to infections
35
Q

List the diagnostic tests for t1DM + explain them

A

o Fasting blood glucose test (blood test taken after fasting overnight)
o Oral glucose tolerance test (blood is taken after fasting overnight. Patient has sugary drink and blood sugar levels are tested 2 hours after drinking)
o Random blood glucose test (Blood sugar levels measured at any time of day)
o Haemoglobin A1C test -measures the average glucose level for the past three months. It measures what percentage of haemoglobin is coated with glucose.

36
Q

What are the 2 main treatment options for T1DM?

A

Insulin injections

Insulin pumps

37
Q

Describe what type of insulin a pump provides and the 2 types of pump treatments

A

provides rapid acting insulin through needle under the skin

Bolus = taken when you need to eat or to give a correction dose if glucose too high
Basal = insulin is continually given throughout the day and night. Can be altered according to how active you are. (still rapid acting, just small amount)
38
Q

What is someone with T1Dm at risk of if they take too much/little insulin or forget to eat/eat too much?

A

 If a person takes too much insulin relative to their dietary intake, or if they forget to eat = dangerous hypoglycaemia.

 If they take too little insulin, or eat too much, they can develop ketoacidosis

39
Q

list the 3 acute complications of t1DM

A

hypoglycaemia
Hyperglycaemia
Diabetic Ketoacidosis

40
Q

Describe the causes and treatments of hypoglycaemia

A
Due to:
	Low carbohydrate intake (e.g. missed meal)
	Unexpected exercise
	Insulin overdose
	Malabsorption 

Treatment:
 Keep a sugary snack close by in case they feel it coming on
 Glucagon pen
 Severe hypoglycaemia can result in a coma – this is treated with IV infusion of 5% dextrose and sugary drinks.

41
Q

Describe the causes and treatments of hyperglycaemia

A
causes:
	Missed insulin  
	High carbohydrate intake 
	Stressed
	Have over treated hypoglycaemia 

Treatment:
 Drink plenty of sugar free drinks
 Take extra insulin

42
Q

Describe the causes and treatments of DKA

A

Due to:
 Being ill from chest infection, flu, UTI
 High blood sugar levels due to puberty/growth spurt
 Not taking insulin
 High blood sugar due to having your period
 Surgery or an injury

Treatment:
	IV infusion of NaCl
	IV infusion of KCl
	IV glucose
	IV insulin
43
Q

list the chronic complications of T1DM

A

retinopathy
peripheral neuropathy
nephropathy

Heart attack/CAD/stroke